Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
Because the epithelial cell adhesion molecule (EpCAM) is a glycoprotein localized on the cell surface, it has been used as a marker for circulating tumor cells (CTC), and the development of a CTC isolation device using EpCAM antibodies has been reported. It was believed that replacing this antibody with an artificial peptide would facilitate the functional analysis of the captured CTC. In this study, Ep114 peptides capable of binding to EpCAM were obtained by using genetic engineering techniques. The Ep114 had a Kd value of 1.6nM and was found to have a strong binding ability with EpCAM. Also, it was confirmed that the Ep114 binds to high-expressing EpCAM cells. Based on these findings, peptides with strong binding ability toward EpCAM were successfully acquired.
|